+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Non-Small Cell Lung Cancer (NSCLC) Market Report 2025 - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Rituximab Biosimilars Market Report 2025 - Product Thumbnail Image

Rituximab Biosimilars Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
From
Monoclonal Antibody Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Monoclonal Antibody Collaboration and Licensing Deals 2019-2024

  • Report
  • November 2024
  • 350 Pages
  • Global
From
From
From
Insulin Biosimilars Market Report 2025 - Product Thumbnail Image

Insulin Biosimilars Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
From
Plaque Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Plaque Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 240 Pages
  • Global
From
From
Loading Indicator